Yuhui Liu

1095 Jiefang Ave
Wuhan, 430030, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

MicroRNA-based strategies to overcome the immunotherapy barrier in pancreatic ductal adenocarcinoma.

MicroRNA-based strategies to overcome the immunotherapy barrier in pancreatic ductal adenocarcinoma.

Journal: Frontiers in immunology

Published: November 12, 2025

USP20-RAB8A signaling axis restricts pancreatic cancer progression by disrupting GLUT1 vesicular trafficking and inhibiting glucose uptake.

USP20-RAB8A signaling axis restricts pancreatic cancer progression by disrupting GLUT1 vesicular trafficking and inhibiting glucose uptake.

Journal: Cancer letters

Published: October 30, 2025

Navigating the complexities of ferroptosis in pancreatic ductal adenocarcinoma: roles, mechanisms and potential applications.

Navigating the complexities of ferroptosis in pancreatic ductal adenocarcinoma: roles, mechanisms and potential applications.

Journal: Cell death discovery

Published: October 14, 2025

Chinese herbal prescription JZ-1 enhances host resistance to herpes simplex virus type 2 through regulating the MRN-ATM-CHK2 DNA damage response.

Chinese herbal prescription JZ-1 enhances host resistance to herpes simplex virus type 2 through regulating the MRN-ATM-CHK2 DNA damage response.

Journal: Journal of ethnopharmacology

Published: August 18, 2025

Identification of a fibroblast-derived gene signature reveals prognostic and therapeutic insights in pancreatic cancer.

Identification of a fibroblast-derived gene signature reveals prognostic and therapeutic insights in pancreatic cancer.

Journal: Clinical and experimental medicine

Published: June 06, 2025

Phosphorylation-dependent STAMBP drives the progression of pancreatic ductal adenocarcinoma by deubiquitinating and stabilizing BAG3.

Phosphorylation-dependent STAMBP drives the progression of pancreatic ductal adenocarcinoma by deubiquitinating and stabilizing BAG3.

Journal: Cell death and differentiation

Published: January 21, 2025

Dysregulated RNA m6A Methylation Contributes to the Metastasis of Gallbladder Cancer Through miR-146a-5p.

Dysregulated RNA m6A Methylation Contributes to the Metastasis of Gallbladder Cancer Through miR-146a-5p.

Journal: Journal of cellular and molecular medicine

Published: January 15, 2025

MiR-200b-3p elevates 5-FU sensitivity in cholangiocarcinoma cells via autophagy inhibition by targeting KLF4.

MiR-200b-3p elevates 5-FU sensitivity in cholangiocarcinoma cells via autophagy inhibition by targeting KLF4.

Journal: Non-coding RNA research

Published: February 02, 2024

TRIM21-Promoted FSP1 Plasma Membrane Translocation Confers Ferroptosis Resistance in Human Cancers.

TRIM21-Promoted FSP1 Plasma Membrane Translocation Confers Ferroptosis Resistance in Human Cancers.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: April 12, 2023

Hypoxia activated HGF expression in pancreatic stellate cells confers resistance of pancreatic cancer cells to EGFR inhibition.

Hypoxia activated HGF expression in pancreatic stellate cells confers resistance of pancreatic cancer cells to EGFR inhibition.

Journal: EBioMedicine

Published: May 19, 2022

LncRNA FAM83H-AS1 promotes the malignant progression of pancreatic ductal adenocarcinoma by stabilizing FAM83H mRNA to protect β-catenin from degradation.

LncRNA FAM83H-AS1 promotes the malignant progression of pancreatic ductal adenocarcinoma by stabilizing FAM83H mRNA to protect β-catenin from degradation.

Journal: Journal of experimental & clinical cancer research : CR

Published: April 22, 2022

A self-amplifying USP14-TAZ loop drives the progression and liver metastasis of pancreatic ductal adenocarcinoma.

A self-amplifying USP14-TAZ loop drives the progression and liver metastasis of pancreatic ductal adenocarcinoma.

Journal: Cell death and differentiation

Published: September 10, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026